BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2899964)

  • 1. Induction of Epstein-Barr virus antigens by hydroxyurea.
    Nováková Z; Roubal J
    Acta Virol; 1988 Mar; 32(2):160-3. PubMed ID: 2899964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns.
    Klein G; Zeuthen J; Ber R; Ernberg I
    J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the expression of Epstein-Barr virus antigens in vitro by Chinese medicine compound "Dongxia wan".
    Huang P; Deng H; Zhao M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):128-30. PubMed ID: 11503041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Epstein-Barr virus early antigen, virus capsid antigen and virus DNA synthesis by mitomycin C.
    Ernberg I; Moar MH
    J Gen Virol; 1981 Jan; 52(Pt 1):39-48. PubMed ID: 6267175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate.
    Prachová K; Roubal J; Vonka V; Brichácek B; Reifová M
    Acta Virol; 1983 Jul; 27(4):329-36. PubMed ID: 6138996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hydrocortisone on the synthesis of Epstein-Barr virus antigens in P3HR-1 cells.
    Prachová K; Roubal J
    Acta Virol; 1981 May; 25(3):163-6. PubMed ID: 6115566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil on Epstein-Barr virus antigen expression in P3HR-1 cells: comparison with acyclovir.
    Färber I; Klinger C; Wutzler P; Thiel KD; Reefschläger J; Herrmann G
    Acta Virol; 1987 Jan; 31(1):13-8. PubMed ID: 2883852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
    Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
    J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the synthesis of Epstein-Barr virus-related antigens induced by superinfection].
    Fujiwara S
    Hokkaido Igaku Zasshi; 1984 Sep; 59(5):586-602. PubMed ID: 6096242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting effects of hydroxyurea on cell growth and reduction in Epstein-Barr virus genomes in EBV-infected epithelioid cell lines vs Burkitt's lymphoma cell lines.
    Jiang R; Kanamori M; Satoh Y; Fukuda M; Ikuta K; Murakami M; Sairenji T
    J Med Virol; 2003 Jun; 70(2):244-52. PubMed ID: 12696111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells.
    Daibata M; Sairenji T
    Virology; 1993 Oct; 196(2):900-4. PubMed ID: 8396819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of kampo medicine on Epstein-Barr virus antigen induction by tumor promoter.
    Furukawa M; Sakashita H; Kamide M; Umeda R
    Auris Nasus Larynx; 1990; 17(1):49-54. PubMed ID: 2167654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo.
    Edson CM; Cohen LK; Henle W; Strominger JL
    J Immunol; 1983 Feb; 130(2):919-24. PubMed ID: 6294181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Suppressive effect of CDDP on induction of the Epstein-Barr virus antigen synthesis by n-butyrate].
    Furukawa M; Kato C; Kamide M; Umeda R
    Nihon Jibiinkoka Gakkai Kaiho; 1989 Feb; 92(2):189-93. PubMed ID: 2545850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of short-chain fatty acids on Epstein-Barr virus early and viral capsid antigen induction in P3HR-1 cells.
    Kawanishi M; Ito Y
    Cancer Lett; 1980 Dec; 11(2):129-32. PubMed ID: 6257378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplicity-dependent induction of viral capsid antigen in Raji cells superinfected with Epstein-Barr virus.
    Fujiwara S; Takada K; Yano S; Osato T
    Virology; 1983 Jul; 128(2):490-4. PubMed ID: 6310870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of retinoic acid (RA) on the Epstein-Barr virus (EBV)-inducing effect of sodium butyrate.
    Roubal J; Luka J; Klein G
    Cancer Lett; 1980 Jan; 8(3):209-12. PubMed ID: 6261939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of actinomycin D and cycloheximide on Epstein-Barr virus early antigen induction in lymphoblastoid cells.
    Yamamoto N; Mueller-Lantzsch N; zur Hausen H
    J Gen Virol; 1980 Dec; 51(Pt 2):255-61. PubMed ID: 6262437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
    Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
    Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.